These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 19499455)

  • 21. Thalamic control of dopaminergic functions in the caudate-putamen of the rat--I. The influence of electrical stimulation of the parafascicular nucleus on dopamine utilization.
    Kilpatrick IC; Phillipson OT
    Neuroscience; 1986 Nov; 19(3):965-78. PubMed ID: 3796823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Release to the cerebral ventricles of substances with possible transmitter function in the caudate nucleus.
    Portig PJ; Vogt M
    J Physiol; 1969 Oct; 204(3):687-715. PubMed ID: 4309959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blockade of dopamine D2, but not of D1 receptors in the rat globus pallidus induced Fos-like immunoreactivity in the caudate-putamen, substantia nigra and entopeduncular nucleus.
    Hauber W; Lutz S
    Neurosci Lett; 1999 Aug; 271(2):73-6. PubMed ID: 10477105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of chronic intraputamenal infusion of glial cell line-derived neurotrophic factor (GDNF) in aged Rhesus monkeys.
    Maswood N; Grondin R; Zhang Z; Stanford JA; Surgener SP; Gash DM; Gerhardt GA
    Neurobiol Aging; 2002; 23(5):881-9. PubMed ID: 12392792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal lesions of the left entorhinal cortex affect dopamine metabolism in the rat brain.
    Uehara T; Tanii Y; Sumiyoshi T; Kurachi M
    Brain Res; 2000 Mar; 860(1-2):77-86. PubMed ID: 10727625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurochemical studies on central dopamine neurons--regional characterization of dopamine turnover.
    Hallman H; Jonsson G
    Med Biol; 1984; 62(3):198-209. PubMed ID: 6492900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Release of dopamine in both caudate nuclei and both substantia nigrae in response to unilateral stimulation of cerebellar nuclei in the cat.
    Nieoullon A; Cheramy A; Glowinski J
    Brain Res; 1978 Jun; 148(1):143-52. PubMed ID: 656921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MPTP-induced parkinsonism: relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubral field of symptomatic and asymptomatic vervet monkeys.
    Elsworth JD; Deutch AY; Redmond DE; Sladek JR; Roth RH
    Brain Res; 1990 Apr; 513(2):320-4. PubMed ID: 2350702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature.
    Adolfsson R; Gottfries CG; Roos BE; Winblad B
    J Neural Transm; 1979; 45(2):81-105. PubMed ID: 381583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey.
    Irwin I; DeLanney LE; Forno LS; Finnegan KT; Di Monte DA; Langston JW
    Brain Res; 1990 Oct; 531(1-2):242-52. PubMed ID: 1981162
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset.
    Gnanalingham KK; Milkowski NA; Smith LA; Hunter AJ; Jenner P; Marsden CD
    Eur J Pharmacol; 1995 Apr; 277(2-3):235-41. PubMed ID: 7493614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [3H]Nitrendipine binding sites are decreased in the substantia nigra and striatum of the brain from patients with Parkinson's disease.
    Nishino N; Noguchi-Kuno SA; Sugiyama T; Tanaka C
    Brain Res; 1986 Jul; 377(1):186-9. PubMed ID: 2942224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced circling preference in rats. Correlation with monoamine levels.
    Ali SF; Kordsmeier KJ; Gough B
    Mol Neurobiol; 1995; 11(1-3):145-54. PubMed ID: 8561958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation.
    Scheller C; Sopper S; Jenuwein M; Neuen-Jacob E; Tatschner T; Grünblatt E; ter Meulen V; Riederer P; Koutsilieri E
    J Neurochem; 2005 Oct; 95(2):377-87. PubMed ID: 16190867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra.
    Fornstedt B; Brun A; Rosengren E; Carlsson A
    J Neural Transm Park Dis Dement Sect; 1989; 1(4):279-95. PubMed ID: 2597314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
    Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
    Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ontogeny of amphetamine-induced dopamine release in the caudate-putamen of the rat.
    Gazzara RA; Fisher RS; Howard SG
    Brain Res; 1986 Aug; 393(2):213-20. PubMed ID: 3742239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats.
    Robinson TE; Whishaw IQ
    Brain Res; 1988 May; 450(1-2):209-24. PubMed ID: 3135914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporal profile of tissue levels of dopamine and its metabolites, HVA and DOPAC following focal cerebral ischaemia in anaesthetized primates.
    Kuruvilla A; Cherian R; Theodore DR; Abraham J
    Clin Exp Pharmacol Physiol; 1986 Jul; 13(7):519-24. PubMed ID: 3791706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus.
    Koulu M; Lappalainen J; Pesonen U; Hietala J; Syvälahti E
    Eur J Pharmacol; 1988 Oct; 155(3):313-6. PubMed ID: 3069483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.